Ticker Details
ICU Medical, Inc. ICU Medical Inc is engaged in the development, manufacture and sale of medical devices used in infusion therapy, oncology and critical care applications. Its products include needlefree connectors, nanoclave, chemoclock, chemoclave, and among others.
IPO Date:	January 3, 1994
Sector:	Healthcare
Industry:	Health Care Equipment and Supplies
Market Cap:	$3.91B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.46 | 1.37%
Avg Daily Range (30 D):	$2.31 | 1.61%
Avg Daily Range (90 D):	$2.20 | 1.66%

Institutional Daily Volume
Avg Daily Volume:	.13M
Avg Daily Volume (30 D):	.21M
Avg Daily Volume (90 D):	.21M

Trade Size
Avg Trade Size (Sh.):	60
Avg Trade Size (Sh.) (30 D):	35
Avg Trade Size (Sh.) (90 D):	32

Institutional Trades
Total Institutional Trades:	3,679
Avg Institutional Trade:	$3.85M
Avg Institutional Trade (30 D):	$7.25M
Avg Institutional Trade (90 D):	$6M
Avg Institutional Trade Volume:	.03M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$4.86M
Avg Closing Trade (30 D):	$9.54M
Avg Closing Trade (90 D):	$7.39M
Avg Closing Volume:	31.35K

News

Jun 10, 2026 @ 11:36 PM ICU Medical's General Counsel Sells — The S... Source: Seena Hassouna

Mar 25, 2026 @ 12:01 PM EXCLUSIVE: Petrochemical Crunch From Iran War Isn'... Source: Eva Mathew

Mar 13, 2026 @ 8:30 AM Intravenous (IV) Solutions Market Size to Reach US... Source: Sns Insider

Mar 9, 2026 @ 10:30 PM [Latest] Global Intravenous Infusion Pump Market S... Source: Custom Market Insights

Aug 8, 2025 @ 1:15 AM ICU Medical (ICUI) Q2 EPS Jumps 40% Source: Jesterai

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$1.87	$1.22	$-.64
Diluted EPS	$1.86	$1.2	$-.63
Revenue	$2.16B	$530.23M	$540.7M
Gross Profit	$818.16M	$206.23M	$202.99M
Net Income / Loss	$46.34M	$30.13M	$-15.73M
Operating Income / Loss	$43.52M	$13.58M	$5.64M
Cost of Revenue	$1.34B	$324M	$337.72M
Net Cash Flow	$-1.37M	$-19.63M	$8.23M
PE Ratio

Splits
Mar 18, 2002	3:2